Post-market Clinical Follow-up Study Plan for Disposable Endoscopic Linear Cutter Stapler

NCT06677008 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 302

Last updated 2024-11-06

No results posted yet for this study

Summary

This study conducted a Post-Market Clinical Follow-Up study (PMCF) to evaluate the safety and effectiveness of the disposable endoscopic linear cutter stapler produced by Changzhou Ankang Medical Instrument Co., Ltd., through a retrospective analysis of the clinical data, to evaluate the safety and effectiveness of soft tissue resection, transection and anastomosis.

Conditions

  • The Expeditious Transection/resection of Tissues and Creation of Anastomoses

Interventions

DEVICE

Disposable endoscopic linear cutter stapler

Investigational devices of all the models of the staplers and its cartridge listed in Study Plan(Plan number: CAK-PMCF)

Sponsors & Collaborators

  • Suzhou Kerui Medical Technology Co., Ltd

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-11-15
Primary Completion
2025-02-28
Completion
2025-02-28

Countries

  • China

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06677008 on ClinicalTrials.gov